1.
Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1.
Markets Covered
1.2.2.
Years Considered for
Study
1.2.3.
Key Market
Segmentations
2.
Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3.
Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5.
France Rapid Test
Kit Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1.
By Type (Rapid Antigen Test, Rapid Antibody Test)
5.2.2.
By Product Type (Over-the-counter
{OTC} Rapid Test Kit, Professional Rapid Test Kit)
5.2.3. By Technology
(Lateral Flow Assays, Solid Phase, Agglutination, Immunospot Assay)
5.2.4. By Duration
(Less than 30 Minutes, Less than 10 Minutes, Less than 1 Hour, 1 Hour - 2 Hour,
Others)
5.2.5. By Application
(Infectious Disease, Glucose Monitoring, Pregnancy & Fertility, Toxicology,
Cardiology, Oncology, Others)
5.2.6. By End
User (Hospitals & Clinics, Home Care, Diagnostic Centers, Others)
5.2.7. By
Region
5.2.8. By
Company (2023)
5.3. Market Map
5.3.1. By Type
5.3.2. By Product Type
5.3.3. By Technology
5.3.4. By Duration
5.3.5. By Application
5.3.6. By End User
5.3.7. By Region
6.
Northern France Rapid
Test Kit Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1.
By Type (Rapid Antigen Test, Rapid Antibody Test)
6.2.2.
By Product Type (Over-the-counter {OTC} Rapid Test Kit,
Professional Rapid Test Kit)
6.2.3.
By Technology (Lateral Flow Assays, Solid Phase,
Agglutination, Immunospot Assay)
6.2.4.
By Duration (Less than 30 Minutes, Less than 10 Minutes,
Less than 1 Hour, 1 Hour - 2 Hour, Others)
6.2.5.
By Application (Infectious Disease, Glucose Monitoring,
Pregnancy & Fertility, Toxicology, Cardiology, Oncology, Others)
6.2.6.
By End User (Hospitals & Clinics, Home Care,
Diagnostic Centers, Others)
7. Southern France Rapid Test Kit Market Outlook
7.1.
Market Size &
Forecast
7.1.1. By Value
7.2.
Market Share &
Forecast
7.2.1.
By Type (Rapid Antigen Test, Rapid Antibody Test)
7.2.2.
By Product Type (Over-the-counter {OTC} Rapid Test Kit,
Professional Rapid Test Kit)
7.2.3.
By Technology (Lateral Flow Assays, Solid Phase,
Agglutination, Immunospot Assay)
7.2.4.
By Duration (Less than 30 Minutes, Less than 10 Minutes,
Less than 1 Hour, 1 Hour - 2 Hour, Others)
7.2.5.
By Application (Infectious Disease, Glucose Monitoring,
Pregnancy & Fertility, Toxicology, Cardiology, Oncology, Others)
7.2.6.
By End User (Hospitals & Clinics, Home Care,
Diagnostic Centers, Others)
8. Western France Rapid Test Kit Market Outlook
8.1.
Market Size &
Forecast
8.1.1. By Value
8.2.
Market Share &
Forecast
8.2.1.
By Type (Rapid Antigen Test, Rapid Antibody Test)
8.2.2.
By Product Type (Over-the-counter {OTC} Rapid Test Kit,
Professional Rapid Test Kit)
8.2.3.
By Technology (Lateral Flow Assays, Solid Phase,
Agglutination, Immunospot Assay)
8.2.4.
By Duration (Less than 30 Minutes, Less than 10 Minutes,
Less than 1 Hour, 1 Hour - 2 Hour, Others)
8.2.5.
By Application (Infectious Disease, Glucose Monitoring,
Pregnancy & Fertility, Toxicology, Cardiology, Oncology, Others)
8.2.6.
By End User (Hospitals & Clinics, Home Care,
Diagnostic Centers, Others)
9. Central France Rapid Test Kit Market Outlook
9.1.
Market Size &
Forecast
9.1.1. By Value
9.2.
Market Share &
Forecast
9.2.1.
By Type (Rapid Antigen Test, Rapid Antibody Test)
9.2.2.
By Product Type (Over-the-counter {OTC} Rapid Test Kit,
Professional Rapid Test Kit)
9.2.3.
By Technology (Lateral Flow Assays, Solid Phase,
Agglutination, Immunospot Assay)
9.2.4.
By Duration (Less than 30 Minutes, Less than 10 Minutes,
Less than 1 Hour, 1 Hour - 2 Hour, Others)
9.2.5.
By Application (Infectious Disease, Glucose Monitoring,
Pregnancy & Fertility, Toxicology, Cardiology, Oncology, Others)
9.2.6.
By End User (Hospitals & Clinics, Home Care,
Diagnostic Centers, Others)
10. Eastern France Rapid Test Kit Market Outlook
10.1.
Market Size &
Forecast
10.1.1. By Value
10.2.
Market Share &
Forecast
10.2.1.
By Type (Rapid Antigen Test, Rapid Antibody Test)
10.2.2.
By Product Type (Over-the-counter {OTC} Rapid Test Kit,
Professional Rapid Test Kit)
10.2.3.
By Technology (Lateral Flow Assays, Solid Phase,
Agglutination, Immunospot Assay)
10.2.4.
By Duration (Less than 30 Minutes, Less than 10 Minutes,
Less than 1 Hour, 1 Hour - 2 Hour, Others)
10.2.5.
By Application (Infectious Disease, Glucose Monitoring,
Pregnancy & Fertility, Toxicology, Cardiology, Oncology, Others)
10.2.6.
By End User (Hospitals & Clinics, Home Care,
Diagnostic Centers, Others)
11. Southwestern France Rapid Test Kit Market Outlook
11.1.
Market Size &
Forecast
11.1.1. By Value
11.2.
Market Share &
Forecast
11.2.1. By Type
(Rapid Antigen Test, Rapid Antibody Test)
11.2.2. By Product
Type (Over-the-counter {OTC} Rapid Test Kit, Professional Rapid Test Kit)
11.2.3. By Technology
(Lateral Flow Assays, Solid Phase, Agglutination, Immunospot Assay)
11.2.4. By Duration
(Less than 30 Minutes, Less than 10 Minutes, Less than 1 Hour, 1 Hour - 2 Hour,
Others)
11.2.5. By Application
(Infectious Disease, Glucose Monitoring, Pregnancy & Fertility, Toxicology,
Cardiology, Oncology, Others)
11.2.6. By End
User (Hospitals & Clinics, Home Care, Diagnostic Centers, Others)
12. Market Dynamics
12.1.
Drivers
12.2.
Challenges
13. Market Trends & Developments
13.1.
Recent Developments
13.2.
Mergers &
Acquisitions
13.3.
Product Launches
14. Policy & Regulatory Landscape
15.
Porter’s Five Forces Analysis
15.1.
Competition in the
Industry
15.2.
Potential of New
Entrants
15.3.
Power of Suppliers
15.4.
Power of Customers
15.5.
Threat of Substitute
Products
16. France Economic Profile
17. Competitive Landscape
17.1. Roche Diagnostics France SAS
17.1.1.
Business Overview
17.1.2.
Product & Service Offerings
17.1.3.
Recent Developments
17.1.4.
Financials (As Reported)
17.1.5.
Key Personnel
17.1.6.
SWOT Analysis
17.2. Abbott Diagnostics (Biological Diagnosis)
17.3. Becton Dickinson Company (France)
17.4. PerkinElmer France
17.5. Siemens Healthineers France
17.6. Bio-Rad (France)
17.7. Meridian Bioscience (France)
17.8. Biomerieux (France)
17.9. Cellex-C France
17.10. Eurobio (France)
17.11. Eurofins France
18.
Strategic Recommendations
19. About Us & Disclaimer